Viewing Study NCT02867592


Ignite Creation Date: 2025-12-24 @ 3:52 PM
Ignite Modification Date: 2025-12-25 @ 8:39 PM
Study NCT ID: NCT02867592
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-02
First Post: 2016-08-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Sponsor: National Cancer Institute (NCI)
Organization: